Provided by Tiger Fintech (Singapore) Pte. Ltd.

DiaMedica Therapeutics Inc.

5.24
+0.03000.58%
Post-market: 5.240.00000.00%16:05 EDT
Volume:120.11K
Turnover:626.90K
Market Cap:224.07M
PE:-9.47
High:5.34
Open:5.25
Low:5.11
Close:5.21
Loading ...

DiaMedica Therapeutics to Participate in Upcoming Craig-Hallum 15th Annual Alpha Select Conference

Business Wire
·
12 Nov 2024

DiaMedica Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
12 Nov 2024

Press Release: DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024

Dow Jones
·
06 Nov 2024

DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024

THOMSON REUTERS
·
06 Nov 2024

New Strong Buy Stocks for October 14th

Zacks
·
14 Oct 2024

Diamedica Therapeutics Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Oct 2024

DiaMedica Says It Receives South Africa Approval to Start Mid-Stage Trial for Preeclampsia Treatment

MT Newswires Live
·
09 Oct 2024

Analysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Diamedica Therapeutics (DMAC)

TIPRANKS
·
09 Oct 2024

BRIEF-Diamedica Therapeutics Announces Regulatory Approval To Begin Phase 2 Trial Of Dm199

Reuters
·
09 Oct 2024

DiaMedica Therapeutics Inc - Dosing to Begin in Q4 2024, Results Expected H1 2025

THOMSON REUTERS
·
09 Oct 2024

DiaMedica Therapeutics Inc - Sahpra Approves Phase 2 Study for Preeclampsia in South Africa

THOMSON REUTERS
·
09 Oct 2024

DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of Dm199 in the Treatment of Preeclampsia

THOMSON REUTERS
·
09 Oct 2024

DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia

Business Wire
·
09 Oct 2024

DiaMedica Therapeutics Insiders Placed Bullish Bets Worth US$9.05m

Simply Wall St.
·
08 Oct 2024

HC Wainwright Initiates DiaMedica Therapeutics at Buy With $7 Price Target

MT Newswires Live
·
07 Oct 2024

Diamedica Therapeutics Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
07 Oct 2024